Skip to content
Abierto
Menu

Combined synopsis and solicitation

PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES

75F40125Q00169

Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in the Social Sciences and Humanities.

View on SAM.govMarkdown

Awarded

Olink Proteomics Inc.

$106,675.00 obligated so far on USAspending

Description

As published on SAM.gov.

Reports of the sample analysis and results of relative quantitation of over 5000 proteins for each of 100 human plasma samples will be delivered. Data provided shall in parquet files, including study design, experimental conditions, and results for each protein analyzed. This analysis will be conducted at the contractor labs, no installation/training are needed. This is also a one-time analysis, there are on option periods.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Olink Proteomics Inc.
UEI
LY8PXLZYEXL7
CAGE
9ASQ1
Vendor location
Waltham, MA
Contract
75F40125P00116, purchase order
Obligated
$106,675.00
Actions
3 between July 22, 2025 and July 14, 2026
Competition
Competed Under SAP, 6 offers received
Set-aside reported
No Set Aside Used.
Described as
Proteomic Analysis of Cancer Patient Plasma Samples
Match
solicitation number 75F40125Q00169 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 6, 2025

    Combined synopsis and solicitation

    Due June 20, 2025 at 5:00 PM EDT. SAM.gov, notice 7b9573e6c4bf47ecb1dc9711fee3b204

Points of contact

Also open from this buyer